Invention Grant
- Patent Title: Gene expressed in prostate cancer
- Patent Title (中): 基因在前列腺癌中表达
-
Application No.: US12211702Application Date: 2008-09-16
-
Publication No.: US07803916B2Publication Date: 2010-09-28
- Inventor: Daniel E. Afar , Rene S. Hubert , Stephen Chappell Mitchell
- Applicant: Daniel E. Afar , Rene S. Hubert , Stephen Chappell Mitchell
- Applicant Address: US CA Santa Monica
- Assignee: Agensys Inc.
- Current Assignee: Agensys Inc.
- Current Assignee Address: US CA Santa Monica
- Agency: Morrison & Foerster LLP
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12N5/12
Abstract:
A novel testis-specific gene expressed in human prostate cancer, designated 22P4F11, is described. Analysis of 22P4F11 mRNA expression in normal prostate, prostate tumor xenografts, and a variety of normal tissues indicates that the expression of this gene is testis specific in normal tissues. The 22P4F11 gene is also expressed in human prostate tumors, in some cases at high levels. A full length cDNA encoding 22P4F11 is provided. The 22P4F11 transcript and/or protein may represent a useful diagnostic marker and/or therapeutic target for prostate cancer.
Public/Granted literature
- US20090098629A1 NOVEL GENE EXPRESSED IN PROSTATE CANCER Public/Granted day:2009-04-16
Information query
